99 related articles for article (PubMed ID: 22997720)
1. [Dynamics of microrheologic properties of erythrocytes in patients with arterial hypertension and dyslipidemia treated with atorvastatin].
Medvedev IN; Skoriatina IA
Klin Med (Mosk); 2012; 90(6):42-5. PubMed ID: 22997720
[TBL] [Abstract][Full Text] [Related]
2. [Effect of atorvastatin on hemorheological parameters in patients with arterial hypertension with dyslipidemia].
Abrashkina ED; Shaalali N; Pakhrova OA; Shutemova EA; Nazarova OA
Kardiologiia; 2010; 50(5):25-8. PubMed ID: 20831044
[TBL] [Abstract][Full Text] [Related]
3. The effects of atorvastatin therapy on rheological characteristics of erythrocyte membrane, serum lipid profile and oxidative status in patients with dyslipidemia.
Uydu HA; Yıldırmış S; Orem C; Calapoglu M; Alver A; Kural B; Orem A
J Membr Biol; 2012 Nov; 245(11):697-705. PubMed ID: 22706680
[TBL] [Abstract][Full Text] [Related]
4. [Erythrocyte aggregation in patients with arterial hypertension and dyslipidemia treated with pravastatin].
Medvedev IN; Skoriatina IA
Klin Med (Mosk); 2014; 92(11):34-8. PubMed ID: 25796944
[TBL] [Abstract][Full Text] [Related]
5. [How to increase the adherence to treatment of patients with arterial hypertension and dyslipidemia: focus on fixed combination of amlodipine and atorvastatin].
Lopatin IuM
Kardiologiia; 2010; 50(7):83-90. PubMed ID: 20659051
[TBL] [Abstract][Full Text] [Related]
6. [The effect of statins on lipids peroxidation and activities of antioxidants enzymes in patients with dyslipidemia].
Broncel M; Koter-Michalak M; Chojnowska-Jezierska J
Przegl Lek; 2006; 63(9):738-42. PubMed ID: 17479860
[TBL] [Abstract][Full Text] [Related]
7. Improving adherence with amlodipine/atorvastatin therapy: IMPACT study.
Oliver S; Jones J; Leonard D; Crabbe A; Delkhah Y; Nesbitt S
J Clin Hypertens (Greenwich); 2011 Aug; 13(8):598-604. PubMed ID: 21806770
[TBL] [Abstract][Full Text] [Related]
8. Effects of low-dose atorvastatin on arterial stiffness and central aortic pressure augmentation in patients with hypertension and hypercholesterolemia.
Kanaki AI; Sarafidis PA; Georgianos PI; Kanavos K; Tziolas IM; Zebekakis PE; Lasaridis AN
Am J Hypertens; 2013 May; 26(5):608-16. PubMed ID: 23449607
[TBL] [Abstract][Full Text] [Related]
9. [A dyslipidemia animal model induced by poloxamer 407 in golden hamsters and pilot study on the mechanism].
Liu Q; Liu SN; Li LY; Chen ZY; Lei L; Zhang N; Shen ZF
Yao Xue Xue Bao; 2011 Apr; 46(4):406-11. PubMed ID: 21751494
[TBL] [Abstract][Full Text] [Related]
10. The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia.
Koter M; Broncel M; Chojnowska-Jezierska J; Klikczynska K; Franiak I
Eur J Clin Pharmacol; 2002 Nov; 58(8):501-6. PubMed ID: 12451426
[TBL] [Abstract][Full Text] [Related]
11. Fixed combination of amlodipine/atorvastatin: from mechanisms to trials.
Ivanovic B; Tadic M
J Cardiovasc Pharmacol Ther; 2013 Nov; 18(6):544-9. PubMed ID: 23832643
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property.
Hyogo H; Yamagishi S; Maeda S; Kimura Y; Ishitobi T; Chayama K
Dig Liver Dis; 2012 Jun; 44(6):492-6. PubMed ID: 22265683
[TBL] [Abstract][Full Text] [Related]
13. Effects of atorvastatin on red-blood cell Na(+)/Li(+) countertransport in hyperlipidemic patients with and without hypertension.
Kosmidou MS; Hatzitolios AI; Adamidou A; Giannopoulos S; Raikos N; Parharidis G; Milionis HJ
Am J Hypertens; 2008 Mar; 21(3):303-9. PubMed ID: 18202666
[TBL] [Abstract][Full Text] [Related]
14. [Effect of atorvastatin treatment on the hemorheologic and hemostatic parameters in chronic cerebrovascular patients].
Szapáry L; Horváth B; Márton Z; Fehér G; Tóth K; Komoly S
Orv Hetil; 2008 Jun; 149(24):1117-23. PubMed ID: 18539578
[TBL] [Abstract][Full Text] [Related]
15. [Pleiotropic effects of atorvastatin and dynamics of quality of life characteristics in patients with hypertensive disease and metabolic syndrome].
Bespalova ID; Kaliuzhin VV; Riazantseva NV; Mediantsev IuA; Osikhov IA; Murashev BIu
Klin Med (Mosk); 2013; 91(12):46-50. PubMed ID: 25702430
[TBL] [Abstract][Full Text] [Related]
16. [Atorvastatin and oxidative stress in coronary heart disease with obesity].
Bondar KY; Belaya OL; Lazutina OM; Kuropteva ZV; Raider LM; Artamoshina NE; Yakovleva TV
Klin Med (Mosk); 2012; 90(10):34-8. PubMed ID: 23285760
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of raloxifene and atorvastatin on serum lipids.
Tsakok AD
J Obstet Gynaecol; 2005 Feb; 25(2):228. PubMed ID: 15814427
[No Abstract] [Full Text] [Related]
18. Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH.
Kimura Y; Hyogo H; Yamagishi S; Takeuchi M; Ishitobi T; Nabeshima Y; Arihiro K; Chayama K
J Gastroenterol; 2010 Jul; 45(7):750-7. PubMed ID: 20112031
[TBL] [Abstract][Full Text] [Related]
19. Amlodipine/atorvastatin fixed-dose combination: a review of its use in the prevention of cardiovascular disease and in the treatment of hypertension and dyslipidemia.
McKeage K; Siddiqui MA
Am J Cardiovasc Drugs; 2008; 8(1):51-67. PubMed ID: 18303938
[TBL] [Abstract][Full Text] [Related]
20. Impact of combination therapy with amlodipine and atorvastatin on plasma adiponectin levels in hypertensive patients with coronary artery disease: combination therapy and adiponectin.
Li M; Xu A; Lam KS; Cheung BM; Tse HF
Postgrad Med; 2011 Nov; 123(6):66-71. PubMed ID: 22104455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]